Compare, Analyse SHASUN PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TEVA PHARMA
Dec-13
SHASUN PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs942,951-   
Low Rs462,564-   
Sales per share (Unadj.) Rs214.21,693.9-  
Earnings per share (Unadj.) Rs5.3105.8-  
Cash flow per share (Unadj.) Rs15.8242.7-  
Dividends per share (Unadj.) Rs1.0092.63-  
Dividend yield (eoy) %1.43.4 42.6%  
Book value per share (Unadj.) Rs53.31,881.6-  
Shares outstanding (eoy) m56.62848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 20.0%   
Avg P/E ratio x13.126.1 50.3%  
P/CF ratio (eoy) x4.411.4 38.9%  
Price / Book Value ratio x1.31.5 89.4%  
Dividend payout %18.787.5 21.4%   
Avg Mkt Cap Rs m3,9582,338,521 0.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM31,959.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,996.5-  
INCOME DATA
Net Sales Rs m12,1271,436,403 0.8%  
Other income Rs m2290-   
Total revenues Rs m12,3561,436,403 0.9%   
Gross profit Rs m1,009393,360 0.3%  
Depreciation Rs m594116,106 0.5%   
Interest Rs m41528,213 1.5%   
Profit before tax Rs m230249,041 0.1%   
Minority Interest Rs m01,131 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-163,482 0.0%   
Tax Rs m-73-3,041 2.4%   
Profit after tax Rs m30289,731 0.3%  
Gross profit margin %8.327.4 30.4%  
Effective tax rate %-31.7-1.2 2,593.1%   
Net profit margin %2.56.2 39.9%  
BALANCE SHEET DATA
Current assets Rs m6,884970,141 0.7%   
Current liabilities Rs m8,456846,045 1.0%   
Net working cap to sales %-13.08.6 -150.0%  
Current ratio x0.81.1 71.0%  
Inventory Days Days6291 67.9%  
Debtors Days Days10896 112.1%  
Net fixed assets Rs m4,970469,161 1.1%   
Share capital Rs m1133,536 3.2%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,0201,595,571 0.2%   
Long term debt Rs m1,817734,465 0.2%   
Total assets Rs m13,3473,282,641 0.4%  
Interest coverage x1.69.8 15.8%   
Debt to equity ratio x0.60.5 130.7%  
Sales to assets ratio x0.90.4 207.6%   
Return on assets %5.43.6 149.6%  
Return on equity %10.05.6 177.9%  
Return on capital %13.34.9 270.2%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398228,888 0.2%  
From Investments Rs m-1,635-81,104 2.0%  
From Financial Activity Rs m1,309-274,567 -0.5%  
Net Cashflow Rs m71-126,783 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.71 Rs / USD

Compare SHASUN PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SHASUN PHARMA With: WYETH LTD  STERLING BIOTECH  PIRAMAL ENTERPRISES  TORRENT PHARMA  ALEMBIC LTD  



Today's Market

Sensex Trades in Green; Tata Motors & Yes Bank Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note tracking global cues. The BSE Sensex is trading up by 133 points while the NSE Nifty is trading up by 46 points.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020 (Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets? (The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

Make the Most of the Smallcap Rebound with These Stocks (Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - VENUS REMEDIES COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS